臺灣博碩士論文加值系統

目錄
指導教授推薦書
論文口試委員審定書
誌謝.......................................................................iii
中文摘要....................................................................iv
英文摘要................................................................... vi
目錄......................................................................viii
圖目錄........................................................................xi
表目錄.........................................................................xii
第一章 緒論...............................................................................1
第一節 研究背景與動機................................................................1
第二節 研究目的.......................................................................4
第二章 文獻探討.....................................................................6
第一節 藥物不良反應之定義........................................................6
第二節 藥物不良反應的分類與評估............................................9
第三節 探查藥物不良反應之方法..............................................13
第四節 藥物特性與藥物不良反應..............................................16
第五節 藥物不良反應其他相關影響因子................19
第六節 藥物不良反應相關醫療耗用研究................22
第三章 研究方法..........................................................................23
第一節 研究架構與設計...............................................................23
第二節 研究假說..........................................................................26
第三節 研究變項及定義..............................................................28
第四節 統計分析..........................................................................36
第四章 研究結果..........................................................................37
第一節 描述性統計......................................................................37
第二節 藥物不良反應之相關因子分析......................................51
第三節 藥物不良反應之醫療資源耗用分析..............................56
第五章 討論.......................................................................... 70
第一節 藥物不良反應通報與系統資料庫......................................70
第二節 全部住院藥物不良反應之總發生率探討.................... 73
第三節 影響發生藥物不良反應之相關因子探討.................... 74
第四節 藥物不良反應導致之醫療資源耗用探討.................... 78
第五節 研究限制........................................................................ 79
第六章 結論與建議...................................................................... 80
第一節 結論............................................................................ 80
第二節 建議........................................................................... 82
參考文獻............................................................................ 83

Al-Tajir, G.K., &; Kelly, W.N. (2005). Epidemiology, comparative methods of detection, and preventability of adverse drug events. The Annals of Pharmacotherapy, 39, 1169-1174.
American Society of Health-System Pharmacists. (1995). ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health-Syst Pharm, 52, 417-419
Bates, D. W., Cullen, D. J., Laird, N., Petersen, L. A., Small, S. D., Servi, D., ... &; Edmondson, A. (1995). Incidence of adverse drug events and potential adverse drug events: implications for prevention. Jama, 274(1), 29-34.
Carbonin, P., Pahor, M., Bernabei, R., &; Sgadari, A. (1991). Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? Journal of the American Geriatrics Society, 39(11), 1093.
Classen, D. C., Pestotnik, S. L., Evans, R. S., Lloyd, J. F., &; Burke, J. P. (1997). Adverse drug events in hospitalized patientsExcess length of stay, extra costs, and attributable mortality. Jama, 277(4), 301-306.
Davies, E., Green, C., Taylor, S., Williamson, P., Mottram, D., &; Pirmohamed, M. (2009). Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One, 4(2), 4439.
Evans, R. S., Lloyd, J. F., Stoddard, G. J., Nebeker, J. R., &; Samore, M. H. (2005). Risk factors for adverse drug events: a 10-year analysis. Annals of Pharmacotherapy, 39(7-8), 1161-1168.
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., ... &; Bates, D. W. (2003). Incidence and preventability of adverse drug events among older persons in the ambulatory setting. Jama, 289(9), 1107-1116.
Hajjar, E., Hanlon, J., Artz, M., Lindblad, C., Pieper, C., Sloane, R., et al. (2003). Adverse drug reaction risk factors in older outpatients. The American Journal of Geriatric Pharmacotherapy, 1(2), 82-89.
Hausmann, O., Schnyder, B., &; Pichler, W. J. (2012). Etiology and pathogenesis of adverse drug reactions.
Johnson, J. A., &; Bootman, J. L. (1995). Drug-related morbidity and mortality: a cost-of-illness model. Archives of Internal Medicine, 155(18), 1949.
Koh, Y., Kutty, F. B. M., &; Li, S. C. (2005). Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender.Therapeutics and clinical risk management, 1(1), 39.
Lazarou, J., Pomeranz, B. H., &; Corey, P. N. (1998). Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.Jama, 279(15), 1200-1205.
Liao, P. J., Shih, C. P., Mao, C. T., Deng, S. T., Hsieh, M. C., &; Hsu, K. H. (2013). The cutaneous adverse drug reactions: risk factors, prognosis and economic impacts. International journal of clinical practice, 67(6), 576-584.
Lucas, C., &; Martin, J. (2013). Smoking and drug interactions. Australian Prescriber, 36(3).
Madsen, J. J. (1993). Comparison of concurrent and retrospective methods of detecting adverse drug reactions. American journal of hospital pharmacy,50(12), 2556-2557.
McDonnell P.J., &; Jacobs, M.R. (2002). Hospital admissions resulting from preventable adverse drug reactions. The Annals of Pharmacotherapy, 36, 1331-1336.
Moore, N., Lecointre, D., Noblet, C., &; Mabille, M. (1998). Frequency and cost of serious adverse drug reactions in a department of general medicine. British journal of clinical pharmacology, 45(3), 301-308.
Muñoz-Torrero, J. F. S., Barquilla, P., Velasco, R., Capitan, M. D. C. F., Pacheco, N., Vicente, L., ... &; Hernandez, A. L. (2010). Adverse drug reactions in internal medicine units and associated risk factors. European journal of clinical pharmacology, 66(12), 1257-1264.
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., ... &; Greenblatt, D. J. (1981). A method for estimating the probability of adverse drug reactions. Clinical Pharmacology &; Therapeutics, 30(2), 239-245.
Peyriere, H., Cassan, S., Floutard, E., Riviere, S., Blayac, J. P., Hillaire-Buys, D., ... &; Hansel, S. (2003). Adverse drug events associated with hospital admission. Annals of Pharmacotherapy, 37(1), 5-11.
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., ... &; Breckenridge, A. M. (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj, 329(7456), 15-19.
Rottenkolber D1, Schmiedl S, Rottenkolber M, Farker K, Saljé K, Mueller S, Hippius M, Thuermann PA, Hasford J(2011). Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf., 20(6),626-34.
Onder, G., Pedone, C., Landi, F., Cesari, M., Della Vedova, C., Bernabei, R., &; Gambassi, G. (2002). Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).Journal of the American Geriatrics Society, 50(12), 1962-1968.
Salmerón-García, A., Barrera, J. C., Pavón, M. J. V., Márquez, E. R., de Miguel, S. C., Vallejo-Rodríguez, I., ... &; Fernández, E. C. (2010). Detection of adverse drug reactions through the minimum basic data set. Pharmacy world &; science, 32(3), 322-328.
Schein, J. R. (1995). Cigarette smoking and clinically significant drug interactions. The Annals of pharmacotherapy, 29(11), 1139-1148.
Senst, B. L., Achusim, L. E., Genest, R. P., Cosentino, L. A., Ford, C. C., Little, J. A., ... &; Bates, D. W. (2001). Practical approach to determining costs and frequency of adverse drug events in a health care network. American Journal of Health-System Pharmacy, 58(12), 1126-1132.
Suh, D. C., Woodall, B. S., Shin, S. K., &; Hermes-De Santis, E. R. (2000). Clinical and economic impact of adverse drug reactions in hospitalized patients.Annals of pharmacotherapy, 34(12), 1373-1379.
Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., &; Ghali, W. A. (2004). New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of clinical epidemiology, 57(12), 1288-1294.
Wodtke, J. M., &; Generali, J. A. (1993). Use of medical record codes to identify adverse drug reactions. American Journal of Health-System Pharmacy, 50(9), 1915-1916.
Wu, W.K.,&; Pantaleo, N. (2003). Evaluation of outpatient adverse drug reactions leading to hospitalization. American Society of Health-System Pharmacy, 60(3), 253-259.
Zevin, S., &; Benowitz, N. L. (1999). Drug interactions with tobacco smoking.Clinical pharmacokinetics, 36(6), 425-438.
王瑩玉、劉惠文(2004)．某教學醫院藥物不良反應之通報與評估．臺灣臨床藥學雜誌，12(1)，1-16。
石崇良、蘇喜(2004)．運用資訊提升病人安全．臺灣醫學，8(6)，807-816。行政院衛生署93年度醫療統計年報。
莊美華、林俊龍、李紀慧(2005)．用藥疏失引起之藥物不良反應分析．台灣臨床藥學雜誌，13(1)，47-62。
顏瑜萱、陳香吟、李友專、龍安靖、邱文達(2004)．電腦支援系統協助用藥安全防護網的建立．醫務管理期刊，5(4)，495-513。
謝政智，「建立醫院內藥物不良反應監測與報告系統」，國立國防醫學院，碩士論文，民國87年。
謝政智、譚延輝、張聖原、回德仁(2002)．某醫院內藥物不良反應之監測結果．台灣臨床藥學雜誌，10(1)，1-13。